Insight 2811, Inc. Pfizer Inc Transaction History

Insight 2811, Inc.

$200 Million
Q1 2024

A detailed history of Insight 2811, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Insight 2811, Inc. holds 11,419 shares of PFE stock, worth $316,306. This represents 0.16% of its overall portfolio holdings.

Number of Shares

11,419

Previous 11,419 -0.0%

Holding current value

$316,306

Previous $328,000 3.66%

% of portfolio

0.16%

Previous 0.17%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $320 - $375	-10 Reduced 0.09%	11,419 $378,000
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $361 - $417	10 Added 0.09%	11,429 $419,000
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $97,923 - $127,482	-2,486 Reduced 17.88%	11,419 $465,000
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $36,072 - $47,088	864 Added 6.63%	13,905 $712,000
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $9,306 - $11,034	-200 Reduced 1.51%	13,041 $684,000

Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $620,187 - $768,489	-13,556 Reduced 50.59%	13,241 $685,000
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $12,561 - $18,620	-304 Reduced 1.12%	26,797 $1.58 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $58,247 - $74,823	-1,484 Reduced 5.19%	27,101 $1.17 Million
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $11,311 - $12,814	-315 Reduced 1.09%	28,585 $1.12 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $16,410 - $18,507	-490 Reduced 1.67%	28,900 $1.05 Million
Q4 2020 Jan 29, 2021	SELL	$33.47 - $42.56 $34,474 - $43,836	-1,030 Reduced 3.39%	29,390 $1.08 Million
Q3 2020 Oct 20, 2020	BUY	$31.75 - $37.25 $9,906 - $11,622	312 Added 1.04%	30,420 $1.12 Million
Q2 2020 Jul 21, 2020	SELL	$30.12 - $36.54 $73,733 - $89,449	-2,448 Reduced 7.52%	30,108 $1.06 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $78,116 - $111,611	-2,890 Reduced 8.15%	32,556 $1.06 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $37,331 - $42,366	1,134 Added 3.3%	35,446 $1.39 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $59,034 - $76,550	-1,817 Reduced 5.03%	34,312 $1.23 Million
Q2 2019 Jul 09, 2019	SELL	$36.98 - $41.52 $17,491 - $19,638	-473 Reduced 1.29%	36,129 $1.6 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $135,562 - $148,938	-3,615 Reduced 8.99%	36,602 $1.55 Million
Q4 2018 Feb 25, 2019	SELL	$38.47 - $43.86 $83,787 - $95,527	-2,178 Reduced 5.14%	40,217 $1.76 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $43,639 - $52,931	-1,266 Reduced 2.9%	42,395 $1.87 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $96,697 - $103,089	-2,932 Reduced 6.29%	43,661 $1.58 Million
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $368,081 - $427,025	11,535 Added 32.9%	46,593 $1.65 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $38,215 - $40,548	-1,149 Reduced 3.17%	35,058 $1.27 Million
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $1.12 Million - $1.24 Million	36,207	36,207 $1.29 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $155B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight 2811, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Insight 2811, Inc. with notifications on news.

Account